GSK plc
GSK
$52.96
$0.791.51%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.11B | 4.54B | 4.60B | 4.44B | 4.96B |
| Total Receivables | 10.70B | 10.47B | 9.92B | 11.16B | 10.55B |
| Inventory | 8.32B | 8.12B | 7.97B | 8.22B | 8.32B |
| Prepaid Expenses | -- | -- | 518.17M | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 128.51M | 295.43M | 546.43M | 153.24M | 390.46M |
| Total Current Assets | 23.26B | 23.42B | 23.57B | 23.98B | 24.21B |
|
|
|||||
| Total Current Assets | 23.26B | 23.42B | 23.57B | 23.98B | 24.21B |
| Net Property, Plant & Equipment | 13.29B | 13.24B | 13.52B | 13.62B | 13.59B |
| Long-term Investments | 9.78B | 9.61B | 9.45B | 9.57B | 9.23B |
| Goodwill | 9.78B | 9.61B | 9.45B | 9.57B | 9.23B |
| Total Other Intangibles | 22.26B | 23.92B | 22.54B | 22.67B | 21.07B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.94B | 11.46B | 11.67B | 11.16B | 11.76B |
| Total Assets | 81.79B | 82.92B | 82.26B | 82.45B | 81.19B |
|
|
|||||
| Total Accounts Payable | 19.00B | 18.74B | 4.76B | 19.56B | 18.70B |
| Total Accrued Expenses | -- | -- | 5.86B | -- | -- |
| Short-term Debt | 5.68B | 320.49M | 1.45B | 721.83M | 376.76M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 6.33B | 2.60B | 3.12B | 2.43B |
| Total Finance Division Other Current Liabilities | 3.84B | 4.19B | 14.12B | 5.28B | 6.41B |
| Total Other Current Liabilities | 3.84B | 4.19B | 14.12B | 5.28B | 6.41B |
| Total Current Liabilities | 28.53B | 29.58B | 28.79B | 28.68B | 27.92B |
|
|
|||||
| Total Current Liabilities | 28.53B | 29.58B | 28.79B | 28.68B | 27.92B |
| Long-Term Debt | 18.55B | 18.55B | 18.95B | 20.02B | 20.97B |
| Short-term Debt | 5.68B | 320.49M | 1.45B | 721.83M | 376.76M |
| Capital Leases | -- | -- | 932.71M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.96B | 11.80B | 12.11B | 12.58B | 12.63B |
| Total Liabilities | 59.03B | 59.94B | 60.78B | 61.28B | 61.52B |
|
|
|||||
| Common Stock & APIC | 6.43B | 6.40B | 6.52B | 6.50B | 6.62B |
| Retained Earnings | 15.19B | 15.29B | 14.75B | 13.46B | 12.05B |
| Treasury Stock & Other | 1.76B | 1.86B | 771.20M | 1.74B | 1.59B |
| Total Common Equity | 23.38B | 23.54B | 22.04B | 21.71B | 20.26B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.38B | 23.54B | 22.04B | 21.71B | 20.26B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -620.01M | -567.12M | -566.62M | -532.30M | -598.71M |
| Total Equity | 22.76B | 22.98B | 21.48B | 21.17B | 19.67B |
|
|
|||||